Publicaciones (65) Publicaciones de MARÍA DULCE NOMBRE GÓMEZ GARRE

2024

  1. Gut Microbiota Signatures with Potential Clinical Usefulness in Colorectal and Non-Small Cell Lung Cancers

    Biomedicines, Vol. 12, Núm. 3

  2. Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma

    Clinical Cancer Research

2023

  1. Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  2. Gut Microbiota and Derived Short-Chain Fatty Acids Are Linked to Evolution of Heart Failure Patients

    International journal of molecular sciences, Vol. 24, Núm. 18

  3. Gut microbiota profiles in feces and paired tumor and non-tumor tissues from Colorectal Cancer patients. Relationship to the Body Mass Index

    PLoS ONE, Vol. 18, Núm. 10 OCTOBER

  4. Non-invasive electromechanical assessment during atrial fibrillation identifies underlying atrial myopathy alterations with early prognostic value

    Nature communications, Vol. 14, Núm. 1, pp. 4613

2022

  1. Relación entre la cuantificación de calcio coronario y la composición de la microbiota intestinal en sujetos sin enfermedad cardiovascular previa: estudio piloto

    Clínica e investigación en arteriosclerosis, Vol. 34, Núm. 4, pp. 205-215

  2. Relationship between the coronary artery calcium quantification and gut microbiota composition in subjects without previous cardiovascular disease: A pilot study

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 4, pp. 205-215

2021

  1. Microglial CX3CR1 production increases in Alzheimer's disease and is regulated by noradrenaline

    GLIA, Vol. 69, Núm. 1, pp. 73-90

2020

  1. Alteración de la microbiota: ¿Qué es lo normal y lo patológico?

    Revista de nutrición práctica, Año 24, pp. 16-16

  2. Gut Microbiota Profile Identifies Transition From Compensated Cardiac Hypertrophy to Heart Failure in Hypertensive Rats

    Hypertension, Vol. 76, Núm. 5, pp. 1545-1554

  3. Identification of a plasma microrna signature as biomarker of subaneurysmal aortic dilation in patients with high cardiovascular risk

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-14

  4. The interaction between mitochondrial oxidative stress and gut microbiota in the cardiometabolic consequences in diet-induced obese rats

    Antioxidants, Vol. 9, Núm. 7, pp. 1-15

2019

  1. The Impact of Cardiac Lipotoxicity on Cardiac Function and Mirnas Signature in Obese and Non-Obese Rats with Myocardial Infarction

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Effect of intensive multifactorial treatment on vascular progenitor cells in hypertensive patients

    PLoS ONE, Vol. 13, Núm. 1

  2. Microbiota intestinal y cáncer de mama

    Revista de nutrición práctica, Año 22, pp. 48-48

2015

  1. Niveles de células progenitoras endoteliales circulantes en pacientes hipertensos tratados

    Hipertensión y riesgo vascular, Vol. 32, Núm. 4, pp. 142-150

2014

  1. Diagnosis of subclinical atherosclerosis in HIV-infected patients: Higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms

    European Journal of Preventive Cardiology, Vol. 21, Núm. 6, pp. 739-748

  2. Functionally defective high-density lipoproteins are related to heightened T-cell activation in vertically HIV-infected adolescents

    Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 265-269

2013

  1. Authors reply: Association of HIV-infection and antiretroviral therapy with levels of endothelial progenitor cells and subclinical atherosclerosis

    Journal of Acquired Immune Deficiency Syndromes